Vaccines (Sep 2022)

Juvenile Membranous Nephropathy Developed after Human Papillomavirus (HPV) Vaccination

  • Haruna Arakawa,
  • Shohei Yokoyama,
  • Takehiro Ohira,
  • Dedong Kang,
  • Kazuho Honda,
  • Yoshihiko Ueda,
  • Akihiro Tojo

DOI
https://doi.org/10.3390/vaccines10091442
Journal volume & issue
Vol. 10, no. 9
p. 1442

Abstract

Read online

A 16-year-old girl with no history of renal disease had a fever of 38 °C after her second HPV vaccination and was identified as positive for proteinuria. As she maintained urinary protein of 3.10 g/gCr and 5–9 urinary red blood cells/HPF, a renal biopsy was performed and small spikes on PAM staining with the granular deposition of IgG1++ and IgG3+ on the glomerular capillary wall were discovered by immunofluorescence, although PLA2R immunostaining was negative. Analysis by electron microscope showed electron density deposition in the form of fine particles under the epithelium. The diagnosis was secondary membranous nephropathy stage II. Immunostaining with the anti-p16 INK4a antibody was positive for glomerular cells, and Western blot analysis of urinary protein showed a positive band for p16 INK4a. However, laser-microdissection mass spectrometry analysis of a paraffin section of glomeruli failed to detect HPV proteins. It is possible that the patient was already infected with HPV and administration of the HPV vaccine may have caused secondary membranous nephropathy.

Keywords